Suppressor-type TERT mutations associated with recurrence in ovarian clear cell carcinoma.

Several cancers harbor "enhancer-type" mutations of the telomerase reverse transcriptase (TERT) promoter for immortalization. Here, we report that 8.6% (8/93) of ovarian clear cell carcinomas (OCCCs) possess the "suppressor-type" TERT promoter mutation. The recurrence rate of OCCCs with "suppressor-type" TERT promoter mutations was 62.5% (5/8) and was significantly higher than that of the "unaffected-type" with no mutation (20.8%, 15/72) or "enhancer-type" TERT promoter mutations (7.7%, 1/13). Our findings show that the acquired suppression of TERT is closely associated with OCCC development and recurrence, indicating the need for further research on telomerase suppression in cancers. © 2023 Wiley Periodicals LLC.

Citation

Tatsuya Kobayashi, Kyoko Nishikimi, Akira Mitsuhashi, Hongying Piao, Ayumu Matsuoka, Satoyo Otsuka, Shinichi Tate, Makio Shozu, Hirokazu Usui. Suppressor-type TERT mutations associated with recurrence in ovarian clear cell carcinoma. Genes, chromosomes & cancer. 2023 Aug;62(8):471-476

Mesh Tags

Substances

PMID: 36710084

search → result